Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Aquatic training in MS: neurotherapeutic impact upon quality of life.
Cell fusion in the brain: two cells forward, one cell back.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Reducing falls and improving mobility in multiple sclerosis.
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
The high cost of spasticity in multiple sclerosis to individuals and society.
Does Slowed Processing Speed Account for Executive Deficits in Multiple Sclerosis? Evidence From Neuropsychological Performance and Structural Neuroimaging.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
Low and High CD8 Positive T cells in Multiple Sclerosis Patients.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Idiopathic Acute Transverse Myelitis in Children: A Retrospective Series.
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Patient and equipment profile for wheelchair seating clinic provision.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
Pages
« first
‹ previous
…
262
263
264
265
266
267
268
269
270
…
next ›
last »